Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest.

Int J Womens Health · 2013 · PMC3684222 · PMID 23788843

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

markedly significantno p-value reported

Markedly significant improvements in hemoglobin, hematocrit, and ferritin were observed in women receiving E2V/DNG compared with little or no improvement in women receiving placebo.

also in 449 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.